Skip to main content

Table 4 Cox univariable analysis for overall survival (OS) according to patient, tumour and treatment modalities characteristicsa

From: Clinical characteristics and prognosis of anal squamous cell carcinoma: a retrospective audit of 144 patients from 11 cancer hospitals in southern China

  Univariable
Variable HR (95%CI) p
Age (years) (> 50 VS. ≤50) 2.90 (1.12–7.49) 0.028
Gender (Male VS. Female) 0.83 (0.33–2.13) 0.702
AJCC stage (III or IV VS. I or II) 4.56 (1.02–20.35) 0.046
T stage (T3 or T4 VS. T1 or T2) 2.33 (0.82–6.63) 0.113
N stage (N1-N3 VS. N0) 3.05 (1.07–8.74) 0.038
Tumor size (> 20 mm VS. ≤20 mm) 0.63 (0.24–1.65) 0.343
History of smoking (Yes VS. No) 1.13 (0.33–3.83) 0.848
Chemotherapy (Yes VS. No) 1.26 (0.46–3.46) 0.652
Radiotherapy (Yes VS. No) 0.81 (0.33–1.96) 0.634
Chemoradiotherapy (Yes VS. No) 0.74 (0.31–1.76) 0.488
  1. a: AJCC American Joint Committee on Cancer; HR Hazard ratio; CI Confidence interval; CRT Chemoradiotherapy